Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03523767 · ClinicalTrials.gov registry record · Phase 1
Effect of Systemic Inflammation on Emotion and Cognition in Patients With Mood Disorder - A Vaccine Study
A Phase 1 study, sponsored by The University of Texas Health Science Center, Houston.
- Terminated
- Registry status
- Phase 1
- Development phase
- 19
- Enrollment target
NCT03523767 is a Phase 1 study that was terminated before completion, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 19 participants.
The verdict
NCT03523767, a Phase 1 study, was terminated before completion, sponsored by The University of Texas Health Science Center, Houston.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 19 participants
- Enrollment target
Study Summary
The purpose of this pilot study is to investigate and compare the effect of a mild inflammatory stimulus (typhoid vaccine) on immune response, mood and cognition in healthy volunteers compared to patients with history Major Depressive Disorder (MDD) (not currently depressed and no symptoms of depression in the past 6 months).
Interventions
- BIOLOGICAL S.typhi Injection
- BIOLOGICAL Normal Saline Injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2018-02-07 |
| Est. Completion | 2020-02-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03523767
The ClinicalTrials.gov registry entry for NCT03523767 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which S.typhi Injection is the first listed.
NCT03523767 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03523767 about?
NCT03523767 is a clinical study titled "Effect of Systemic Inflammation on Emotion and Cognition in Patients With Mood Disorder - A Vaccine Study". The purpose of this pilot study is to investigate and compare the effect of a mild inflammatory stimulus (typhoid vaccine) on immune response, mood and cognition in healthy volunteers compared to patients with history Major Depressive Disorder (MDD) (not currently depressed and no symptoms of depres...
What is the current status of trial NCT03523767?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 19 participants. The study started on 2018-02-07. Estimated completion is 2020-02-07.
What interventions are being tested in trial NCT03523767?
The interventions under investigation include: S.typhi Injection (BIOLOGICAL), Normal Saline Injection (BIOLOGICAL).
Who is sponsoring clinical trial NCT03523767?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.